Background: There is a need for non-invasive parameters that are sensitive to the development of the bronchiolitis obliterans syndrome (BOS) in lung transplantation (LTx) patients. We studied whether the pulmonary diffusing capacity for inhaled nitric oxide is capable of detecting BOS stages. Methods: Sixty-one LTx patients were included into this cross-sectional study (19/29/7/3/3 in BOS stages 0/0-p/1/2/3). For analysis stages 0/0-p versus 1/2/3 ("BOS binary-early"), and stages 0/0-p/1 versus 2/3 ("BOS binary-late") were summarized. Measurements of the combined diffusing capacity for nitric oxide (DLNO) and carbon monoxide (DLCO) were compared with spirometry and bodyplethysmography, and their relative importance was evaluated by discrimi...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
AbstractBronchiolitis obliterans syndrome (BOS) is a significant post-transplant complication with l...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...
Background: There is a need for non-invasive parameters that are sensitive to the development of the...
Background: Exhaled nitric oxide (eNO) and carbon monoxide (eCO) are markers of pulmonary inflammati...
Bronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is characterized by airf...
BACKGROUND Development of bronchiolitis obliterans syndrome (BOS) is a great limitation for patient ...
SummaryBronchiolitis obliterans syndrome (BOS) following lung transplantation is common and potentia...
AbstractChronic obstructive pulmonary disease (COPD) is now the most common indication for single lu...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
Rationale: Early diagnosis of bronchiolitis obliterans syndrome (BOS) is critical in understanding ...
AbstractNoninfectious pulmonary syndromes (NIPS) frequently complicate allogeneic stem cell transpla...
The main limitation for overall survival after lung transplantation (LTx) is the development of chro...
OBJECTIVE: To evaluate the diagnostic value of function volume/morphological volume ratio calculated...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
AbstractBronchiolitis obliterans syndrome (BOS) is a significant post-transplant complication with l...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...
Background: There is a need for non-invasive parameters that are sensitive to the development of the...
Background: Exhaled nitric oxide (eNO) and carbon monoxide (eCO) are markers of pulmonary inflammati...
Bronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is characterized by airf...
BACKGROUND Development of bronchiolitis obliterans syndrome (BOS) is a great limitation for patient ...
SummaryBronchiolitis obliterans syndrome (BOS) following lung transplantation is common and potentia...
AbstractChronic obstructive pulmonary disease (COPD) is now the most common indication for single lu...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival af...
Rationale: Early diagnosis of bronchiolitis obliterans syndrome (BOS) is critical in understanding ...
AbstractNoninfectious pulmonary syndromes (NIPS) frequently complicate allogeneic stem cell transpla...
The main limitation for overall survival after lung transplantation (LTx) is the development of chro...
OBJECTIVE: To evaluate the diagnostic value of function volume/morphological volume ratio calculated...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
AbstractBronchiolitis obliterans syndrome (BOS) is a significant post-transplant complication with l...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...